Supplemental material
Acta Oncologica
Volume 62, 2023 - Issue 12
Open access
1,565
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology
Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi study
Jürgen Geislera Department of Oncology, University of Oslo and Akershus University Hospital, Akershus, NorwayView further author information
, Peeter Karihtalab Department of Oncology, Helsinki University Hospital Comprehensive Cancer Centre and University of Helsinki, Helsinki, FinlandCorrespondence[email protected]
View further author information
, View further author information
Malgorzata Tuxenc Department of Oncology, University of Copenhagen Herlev Hospital, Copenhagen, DenmarkView further author information
, Antonis Valachisd Department of Oncology, Örebro University Hospital, Örebro, SwedenView further author information
, Delphi Panellist Group & Barbro Holme Department of Oncology, Novartis, Stockholm, SwedenView further author information
Cecilia Ahlinf Department of Oncology, Karlstad Hospital, Karlstad, SwedenView further author information
, Cathrine Bergquist Fosskaugg Akershus University Hospital, Akershus, NorwayView further author information
, Jenny Bergqvisth Department of Medical Epidemiology and Biostatistics/Kirurgmottagningen, Karolinska Institutet and Capio St Görans sjukhus, Stockholm, SwedenView further author information
, Ana Bosch Camposi Department of Hematology, Oncology and Radiotherapy, Lund University Hospital, Lund, SwedenView further author information
, Eva Harder Brixj Herlev and Gentofte Hospital, Herlev/Gentofte, DenmarkView further author information
, Erik Hugger Jakobsenk Sygehus Sønderjylland, Sønderborg, DenmarkView further author information
, Anders Bonde Jensenl Aarhus University Hospital, Aarhus, DenmarkView further author information
, Oskar Johannssonm Landspitali Hospital, Reykjavik, IcelandView further author information
, Minna Jääskeläinenn Lapland Central Hospital, Rovaniemi, FinlandView further author information
, Torgunn Kursetgjerdeo Møre and Romsdal Hospital, Ålesund, NorwayView further author information
, Barbro Linderholmp Department of Oncology, Sahlgrenska Academy and University Hospital, Gothenburg, SwedenView further author information
, Henrik Lindmanq Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology and Clinical Oncology, Uppsala University Hospital, Uppsala, SwedenView further author information
, Bård Mannsåkerr Nordland Hospital, Bodø, NorwayView further author information
, Ulrik Narbes Växjö Regional Hospital, Växjö, SwedenView further author information
, Alina Carmen Porojnicut Vestre Viken Hospital, Drammen, NorwayView further author information
, Katri Selanderu Oulu University hospital, Oulu, FinlandView further author information
, Silje Songe-Møllerv Østfold Hospital, Kalnes, NorwayView further author information
, Egil Støre Blixw University Hospital of North Norway HF, Tromsø, NorwayView further author information
, Ann Søegaard Knopx Rigshospitalet/Copenhagen University Hospital, Copenhagen, DenmarkView further author information
, Anna Thuliny Department of Oncology, Sahlgrenska Academy, Gothenburg, SwedenView further author information
, Leena Tiainenz Tampere University Hospital, Tampere, FinlandView further author information
, Anna Wederaa Mälarsjukhuset Hospital, Eskilstuna, SwedenView further author information
& Sophie Yammenibb Aalborg University Hospital, Aalborg, DenmarkView further author information
show all
Pages 1680-1688
|
Received 09 Feb 2023, Accepted 06 Aug 2023, Published online: 15 Sep 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.